{
  "resourceType": "MedicationStatement",
  "id": "ImmunosuppresivePermanentMedication",
  "meta": {
    "profile": [
      "https://www.napkon.de/fhir/StructureDefinition/immunosuppresive-permanent-medication"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b>Generated Narrative</b></p><p><b>status</b>: completed</p><p><b>medication</b>: <span title=\"Codes: {https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module P7}, {http://fhir.de/CodeSystem/bfarm/atc L01XC19}\">Anti-CD3/CD19 antibody</span></p><p><b>subject</b>: <a href=\"Patient-ExamplePatient.html\">Generated Summary: Medical record number: napkon-example-patient; maxi musterperson (OFFICIAL); gender: unknown; birthDate: 1990-08-08</a></p><p><b>effective</b>: Sep 14, 2021, 11:06:00 AM</p></div>"
  },
  "status": "completed",
  "medicationCodeableConcept": {
    "coding": [
      {
        "system": "https://www.netzwerk-universitaetsmedizin.de/fhir/CodeSystem/napkon-pediatrics-module",
        "code": "P7",
        "display": "Anti-CD3/CD19 antibody"
      },
      {
        "system": "http://fhir.de/CodeSystem/bfarm/atc",
        "code": "L01XC19",
        "display": "Blinatumomab"
      }
    ]
  },
  "subject": {
    "reference": "Patient/ExamplePatient"
  },
  "effectiveDateTime": "2021-09-14T13:06:00+02:00"
}